We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.76B
AUM Growth
-$256M
Cap. Flow
-$351M
Cap. Flow %
-19.91%
Top 10 Hldgs %
49.94%
Holding
89
New
12
Increased
13
Reduced
24
Closed
14

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$39.7M
2
DXCM icon
DexCom
DXCM
+$26.2M
3
EW icon
Edwards Lifesciences
EW
+$25.4M
4
BSX icon
Boston Scientific
BSX
+$18.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$18.8M

Sector Composition

Rank Sector Weight
1 Healthcare 95.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
76
DexCom
DXCM
$31.3B
-231,007
Closed -$26.2M
EYPT icon
77
EyePoint Inc
EYPT
$1.08B
-292,926
Closed -$2.55M
IWM icon
78
PUT
iShares Russell 2000 ETF
IWM
$82.1B
-70,700
Closed -$14.3M
JNJ icon
79
Johnson & Johnson
JNJ
$619B
-128,825
Closed -$18.8M
MDGL icon
80
Madrigal Pharmaceuticals
MDGL
$11.8B
-29,973
Closed -$8.4M
OM icon
81
Outset Medical
OM
$96.4M
-49,640
Closed -$2.87M
QQQ icon
82
CALL
Invesco QQQ Trust
QQQ
$479B
-187,400
Closed -$89.8M
SANA icon
83
Sana Biotechnology
SANA
$949M
-110,834
Closed -$605K
TNYA icon
84
Tenaya Therapeutics
TNYA
$157M
-222,222
Closed -$689K
UNH icon
85
CALL
UnitedHealth
UNH
$367B
-52,400
Closed -$26.7M
VKTX icon
86
Viking Therapeutics
VKTX
$3.88B
-58,811
Closed -$3.12M
WAY
87
Waystar Holding Corp
WAY
$4.48B
-35,000
Closed -$753K

Similar funds

PFM Health Sciences's Q3 2024 Portfolio in Review

As of Q3 2024, PFM Health Sciences held 89 positions worth $1.76B, down 13% from $2.02B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

PFM Health Sciences withdrew a net $351M in Q3 2024, closing 14 positions and reducing 24 holdings. Its most notable exit was Centene, an estimated $39.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 89% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Inspire Medical Systems worth $20.8M.

  • PFM Health Sciences's largest Q3 2024 buy was Inspire Medical Systems: 98,322 shares worth $20.8M.
  • PFM Health Sciences added most to Acadia Healthcare in Q3 2024, an estimated $19.2M increase.
  • PFM Health Sciences's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $25.4M.
  • PFM Health Sciences fully exited Centene in Q3 2024, selling an estimated $39.7M.
  • PFM Health Sciences's ten largest holdings make up 50% of its $1.76B portfolio in Q3 2024.
  • PFM Health Sciences opened 12 new positions and closed 14 in Q3 2024.
  • PFM Health Sciences's portfolio value fell 13% quarter-over-quarter to $1.76B.

Based on PFM Health Sciences's 13F filing for Q3 2024, filed 14 Nov 2024.